Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints… (NCT02916940) | Clinical Trial Compass
CompletedPhase 2
Injection of Corticoids for the Treatment of Acute Sprains of the Proximal Interphalangeal Joints of the Fingers.
Belgium60 participantsStarted 2016-11-16
Plain-language summary
There is currently no real consensus on the optimal management of acute sprains of the proximal interphalangeal joint of the long fingers.
The aim of this study is to assess the beneficial effect of an injection of corticosteroids for the treatment of this type of sprain (one single sub-cutaneous injection, in the acute phase). This treatment, if effective, might become the treatment of choice for these types of injuries, instead of a prolonged immobilization or a careful early mobilization.
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults over 18 years old
* Type I and II and III of the Eaton classification (except if fracture/luxation with more than 50% of the articular surface injured)
* Trauma of one articulation only
* Consultation within 2 weeks of trauma
Exclusion Criteria:
* Patients under 18 years old and over 80 years old
* Pregnant/nursing women
* Eaton classification Type II with a fracture affecting more than 50% of the articular surface, or persistant instability after reduction.
* Open wounds, nerve lesion with sensitive issue and any wound needing a surgical intervention
* Underlying pathologies: rhumatological, neurological, congenital (giving hyperextensive articulations as a result)
* Corticoids allergy
* Infection within the treated zone
* Trauma antecedents at the level of the tendons.